Carl Zeiss Meditec AG
Company Profile
Business description
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world. Its ophthalmology segment, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, intraocular lenses, and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. The microsurgery segment is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% share, Zeiss is the clear leader in this market.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEUT: +49 3641220115
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2027
Employees
5,798
Stocks News & Analysis
stocks
This former ASX tech darling is now 25% undervalued
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,261.80 | 6.00 | -0.06% |
| CAC 40 | 8,278.59 | 45.30 | 0.55% |
| DAX 40 | 26,347.45 | 80.26 | 0.31% |
| Dow JONES (US) | 52,231.89 | 157.86 | -0.30% |
| FTSE 100 | 10,751.59 | 31.28 | -0.29% |
| HKSE | 24,557.04 | 108.09 | 0.44% |
| NASDAQ | 25,065.87 | 187.27 | -0.74% |
| Nikkei 225 | 60,831.77 | 372.19 | 0.62% |
| NZX 50 Index | 14,151.25 | 16.16 | -0.11% |
| S&P 500 | 7,520.93 | 29.01 | -0.38% |
| S&P/ASX 200 | 9,126.70 | 2.30 | -0.03% |
| SSE Composite Index | 3,663.70 | 0.02 | -0.00% |